Our advisory team provides the necessary insight to develop and bring to market a disruptor technology



Elliot Alpher, DDS


Founder and Director, The Alpher Center for Sleep Disorders & Jaw Pain

Dr. Elliott Alpher has specialized in the treatment of sleep disorders and jaw pain for more than 25 years. He is on staff at George Washington University Hospital and Georgetown University Hospital, thanks to his development of conservative, non-invasive methods to diagnose and treat TMJ, snoring, and obstructive sleep apnea. He was one of the first practitioners in the Washington, DC area to utilize an intra-oral digital impression system. Dr. Alpher is a Diplomate of the American Board of Craniofacial Pain & Dental Sleep Medicine and The American Sleep and Breathing, Academy. He was also responsible for heading a delegation to the Federal Motor Carrier Safety Administration (FMCSA) to introduce the new technology of compliance chips in oral appliances, to advance treatment of sleep apnea and monitor compliance, for truckers and other transportation personnel. Over the past two decades, Dr. Alpher has worked diligently to generate public awareness of craniofacial pain disorders. He has lectured throughout the United States, Europe and South America, and has authored multiple studies on sleep disorders and TMJ pain.



James W. Hawkins

MBA, PhD, Managing Director, FOCUS Investment Banking

James (Jim) W. Hawkins, MBA, PhD, has been a Managing Director for the past twelve years at Focus Investment Banking, a middle market investment bank in Washington DC specializing in mergers and acquisitions and corporate finance. Dr. Hawkins practices in the firm’s Healthcare and Life Sciences Group. During the 15 years prior to Dr. Hawkins career at the investment bank, Dr. Hawkins served as President and CEO of five early stage biotechnology companies and Chairman of a sixth and has had experience in all major areas of the biopharmaceutical industry including. Dr. Hawkins received his baccalaureate degree in biology from the University of Western Ontario, London, Ontario, Canada, his MBA degree from George Mason University, Fairfax, Virginia, and his doctorate in molecular biology from Baylor College of Medicine in Houston, Texas. He conducted post-doctoral studies at the National Institutes of Health in Bethesda, Maryland, and subsequently served as an Assistant Professor at the Hébèrt School of Medicine, Uniformed Services University of the Health Sciences, also in Bethesda, Maryland. Dr. Hawkins is currently an Adjunct Professor at Georgetown University.